Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia.
Mult Scler Relat Disord
; 44: 102315, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32593144
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Agammaglobulinemia
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2020
Document type:
Article